US FDA Staff Cuts: Biopharma Industry Braces For Impact, But First Wants Clarity On Losses

 
• By Sue Sutter
  
Sand storm
Industry is waiting for the dust to settle on the FDA's staff cuts. (Shutterstock)

More from US FDA

More from Agency Leadership